Drugs Policy

Debate between Lord Ahmad of Wimbledon and Baroness Meacher

Thursday 26th June 2014 Lords Chamber

[Baroness Meacher]

To ask Her Majesty’s Government what plans they have to contribute to the work of the European Union to prepare for the United Nations General Assembly Special Session on Drug Policy in 2016.

[Lord Ahmad of Wimbledon (Con)]

My Lords, the Government are committed to taking a leadership role in preparing for the United Nations General Assembly Special Session on Drugs, including through our representations in the European Union. Of course, we must work with our international partners to share our expertise and indeed to promote a balanced and evidence-based approach to drugs that is within international drug control conventions.

[Baroness Meacher (CB)]

I thank the Minister for his reply. On 26 June 2013, the UN Secretary-General, Ban Ki-moon, appealed to all member states to consider “all options” in drug policy in the lead-up to the 2016 UN special session. Yesterday the former UK ambassador to Afghanistan claimed that to put doctors and pharmacists in control of heroin supply in the UK—with tough regulation—will save lives, improve health and reduce crime. Will the Minister assure the House that the Government will extend their review of drug policy to include a rigorous, independent study of the costs and benefits of a regulatory regime as proposed by our former ambassador—and if not, why not?

[Lord Ahmad of Wimbledon]

First, I pay tribute to the work the noble Baroness has done in this field. She has brought to the fore on many occasions the importance of reviewing drugs policy. The Government have taken a broad view of this. If we look at the statistics, it is commendable that drug usage domestically is down and we have seen a greater emphasis being put on helping people overcome drugs issues. Nevertheless, she may well be aware that there is an international comparators report due within the next two to three months, and we will be reviewing what we find in terms of best practice across a range of countries, not just within the EU.

New Psychoactive Substances: EUC Report

Debate between Lord Ahmad of Wimbledon and Baroness Meacher

Monday 11th November 2013 Lords Chamber

[Baroness Meacher]

Will the Minister accept that the UK Border Agency, leading ACPO officers and many other officials and experts in the field will say that even if a new psychoactive substance is banned, that does not mean that children and young people all over the country are not getting it? They are. The UK Border Agency, for example, talked about its great big warehouse with mountains of little packages; it has no idea what is in those packages—just lots and lots of white powders. Those packages are seized from the post, but the UKBA says that it is a drop in the ocean: it is not touching it or scraping at the edge of the thing at all. Will the Minister accept that we do not and cannot control these new psychoactive substances because they are purchased on the web and delivered direct to children’s and young people’s homes? Therefore, we need a more sophisticated approach to this, which is why the European Union has come to the conclusion that we need to think about the low-risk substances—to differentiate, have a proportionate response and so on. It is just not good enough to say, “We have a system; it works”. The fact is that it does not; the Government’s people recognise that it is not working.

[Lord Ahmad of Wimbledon]

I thank the noble Baroness for her intervention and, of course, for the excellent work she does in her chairmanship of the APPG. I do not for a moment suggest—nor do the Government take this position—that everything can be controlled through such measures. She pointed to the internet: internet purchasing of NPS is quite low. I understand it is at the rate of about 2%. That said, there has to be an acceptance that, of course, banning something does not mean that a substance or a derivative of one will not get through. After all, these are derivatives of what already exists in the market and, as all noble Lords acknowledge, this is unfortunately a dynamic market and you can never control what new substances are coming. It is only possible when something is identified. However, currently we take account of the different representations made by different agencies and we work with EU partners in sharing information and good practice. That is something that the Government subscribe to. However, as the noble Baroness herself acknowledged in her contributions, the UK is far ahead of others in identifying and dealing with some of these matters. Of course, we ultimately need to ensure that we try to stop as quickly as possible these drugs that are coming on to our markets and streets and appearing in people’s homes. There is no doubt that challenges remain and we need to address them as they arise.

Finally, as I already said in acknowledging some of the noble Baroness’s remarks, the Government retain our position that the European Union has a role to play in tackling new psychoactive substances, but we are not convinced that the current measures will add value to the work that the UK is already doing and leading in this area.